PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain

Value in Health ◽

10.1016/j.jval.2020.08.1152 ◽

2020 ◽

Vol 23 ◽

pp. S596

Author(s):

R. Ferrando ◽

M. Echave ◽

N. Espinoza Cámac ◽

S. Maratia ◽

M.Á. Casado

Keyword(s):

Cost Analysis ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Household Productivity

Download Full-text

OP0107 Improvements in Work and Household Productivity after 24 Weeks of Certolizumab Pegol in Treatment of Axial Spondyloarthritis Patients, Including Patients with Ankylosing Spondylitis: Results of Rapid-Axspa Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.312 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A87.1-A87

Author(s):

D. van der Heijde ◽

J. Braun ◽

M. Rudwaleit ◽

O. Purcaru ◽

A. Kavanaugh

Keyword(s):

Ankylosing Spondylitis ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Household Productivity

Download Full-text

Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

Value in Health ◽

10.1016/j.jval.2016.09.1153 ◽

2016 ◽

Vol 19 (7) ◽

pp. A546

Author(s):

D van der Heijde ◽

J Braun ◽

M Rudwaleit ◽

R Landewé ◽

O Purcaru ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Social Participation ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Household Productivity

Download Full-text

SAT0389 Long-Term Improvements in Workplace and Household Productivity and Social Participation over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3235 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 809.1-809

Author(s):

D. van der Heijde ◽

J. Braun ◽

M. Rudwaleit ◽

R. Landewé ◽

O. Purcaru ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Social Participation ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Household Productivity

Download Full-text

Continued Improvements in Workplace and Household Productivity with Certolizumab Pegol Treatment in Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 48-Week Results from the Rapid-axSpA Study

Value in Health ◽

10.1016/j.jval.2013.08.1530 ◽

2013 ◽

Vol 16 (7) ◽

pp. A570

Author(s):

D. van der Heijde ◽

J. Braun ◽

M. Rudwaleit ◽

O. Purcaru ◽

A. Kavanaugh

Keyword(s):

Ankylosing Spondylitis ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Household Productivity

Download Full-text

Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

Value in Health ◽

10.1016/j.jval.2014.08.2653 ◽

2014 ◽

Vol 17 (7) ◽

pp. A387

Author(s):

der Heijde D. van ◽

J. Braun ◽

M. Rudwaleit ◽

O. Purcaru ◽

A. Kavanaugh

Keyword(s):

Ankylosing Spondylitis ◽

Social Participation ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Household Productivity

Download Full-text

Effect Of Certolizumab Pegol On Workplace And Household Productivity In United States Patients With Rheumatoid Arthritis With Or Without Prior Anti-Tnf Exposure: Results From The Predict Study

Value in Health ◽

10.1016/j.jval.2014.03.311 ◽

2014 ◽

Vol 17 (3) ◽

pp. A53 ◽

Author(s):

A. Kavanaugh ◽

P.J. Mease ◽

V. Strand ◽

O. Purcaru ◽

J.R. Curtis

Keyword(s):

Rheumatoid Arthritis ◽

United States ◽

Certolizumab Pegol ◽

Household Productivity ◽

Download Full-text

Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis

RMD Open ◽

10.1136/rmdopen-2017-000430 ◽

2017 ◽

Vol 3 (1) ◽

pp. e000430 ◽

Author(s):

Jürgen Braun ◽

Xenofon Baraliakos ◽

Kay-Geert Hermann ◽

Robert Landewé ◽

Pedro M Machado ◽

...

Keyword(s):

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Sacroiliac Joints

Download Full-text

AB0698 EFFECTIVENESS AND SAFETY OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN REAL-WORLD CLINICAL PRACTICE IN EUROPE: RESULTS FROM A PROSPECTIVE NON-INTERVENTIONAL 12-MONTH COHORT STUDY

10.1136/annrheumdis-2019-eular.1707 ◽

2019 ◽

Author(s):

Xenofon Baraliakos ◽

Torsten Witte ◽

Luc De Clerck ◽

Bruno Frediani ◽

Eduardo Collantes-Estévez ◽

...

Keyword(s):

Cohort Study ◽

Clinical Practice ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol

Download Full-text

SAT0545 Comparing Health-Related Quality of Life across Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis: Analyses from Certolizumab Pegol Clinical Trial Baseline Data

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.2269 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A766.2-A767 ◽

Author(s):

P. J. Mease ◽

A. van Tubergen ◽

A. Deodhar ◽

G. Coteur ◽

T. Nurminen ◽

...

Keyword(s):

Quality Of Life ◽

Rheumatoid Arthritis ◽

Clinical Trial ◽

Psoriatic Arthritis ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Health Related Quality ◽

Related Quality ◽

Download Full-text

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-204231 ◽

2013 ◽

Vol 73 (1) ◽

pp. 39-47 ◽

Author(s):

R Landewé ◽

J Braun ◽

A Deodhar ◽

M Dougados ◽

W P Maksymowych ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Axial Spondyloarthritis ◽

Certolizumab Pegol ◽

Signs And Symptoms ◽

Phase 3 ◽

Download Full-text